Benefits Epithalon + GHK-Cu is believed to help with: Multi-pathway longevity support: Epithalon has been reported in cell, animal, and early human studies to extend telomeres, improve aging biomarkers, support melatonin output, and potentially reduce age-related mortality, though data remain preliminary and largely from Russian cohorts. Deeper rest and circadian balance: By acting on pineal cells and melatonin pathways, Epithalon may help resync sleepwake cycles and nighttime recovery, which Better Med Spa amplifies with sleep hygiene and lightexposure coaching. Collagenrich, firmer skin: GHKCu has been shown to increase collagen and elastin production, enhance dermal matrix organization, accelerate wound healing, and visibly improve wrinkles and texture in topical and injectable studies. Youthful gene signaling: GHKCu can shift thousands of genes toward a more youthful expression profile, including antioxidant, anti-inflammatory, and regenerative pathways, complementing Epithalons broader geroprotective effects. Holistic protocol design: At Better Med Spa, Cellular Reset is integrated with labs, recovery rituals, and KBeauty facials so clients feel and see the impactfrom deeper sleep to more luminous skin and resilience.

It has also been indicated that riboflavin deficiency decreases the mRNA level of antioxidant enzymes in muscle (GR, GPx, SOD and CAT) (Reference Jiang, Chen and Liu33) , intestine (GR, GPx and SOD) (Reference Chen, Feng and Jiang34) and gills (GR, SOD) (Reference Chen, Feng and Jiang35) of fish
Chemical Structure: Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (13 AAs) Alternative Names: Scenesse, Melanotan 1, Afamelanotide CAS Number: 75921-69-6 WHAT IS MT-1 The MT-1 peptide, officially known as Afamelanotide, is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH)
By flushing out free radicals from the body, it can help with diabetes and related complications
Ensure skin is clean, then lightly disperse the product around the parameter of the face
Independent clinical trials examining the complete myGLP system do not exist yet